SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4ZS'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 5 / 12 | LEU A 664LEU A 665GLY A 616THR A 611ILE A 595 | 4ZS A 901 (-3.6A)NoneNone4ZS A 901 (-3.2A)4ZS A 901 (-4.3A) | 1.44A | 1p93A-5ezrA:undetectable | 1p93A-5ezrA:16.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWH_A_BAXA1723_2 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 4 / 6 | ILE A 540VAL A 548ILE A 594ILE A 653 | 4ZS A 901 (-4.2A)4ZS A 901 (-4.8A)NoneNone | 0.77A | 1uwhA-5ezrA:20.0 | 1uwhA-5ezrA:15.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 4 / 7 | ILE A 540LYS A 563ILE A 594ASP A 675 | 4ZS A 901 (-4.2A)4ZS A 901 (-3.9A)NoneNone | 0.87A | 1uwjA-5ezrA:10.3 | 1uwjA-5ezrA:15.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 4 / 7 | ILE A 540LYS A 563ILE A 594ILE A 653 | 4ZS A 901 (-4.2A)4ZS A 901 (-3.9A)NoneNone | 0.87A | 1uwjA-5ezrA:10.3 | 1uwjA-5ezrA:15.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_A_B49A1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 7 / 12 | ILE A 540ARG A 542VAL A 548ALA A 561ILE A 595LEU A 613LEU A 664 | 4ZS A 901 (-4.2A)None4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A)4ZS A 901 (-4.7A)4ZS A 901 (-3.6A) | 0.66A | 2y7jA-5ezrA:27.8 | 2y7jA-5ezrA:18.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_A_B49A1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 7 / 12 | ILE A 540VAL A 548ALA A 561ILE A 595LEU A 613GLU A 618LEU A 664 | 4ZS A 901 (-4.2A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A)4ZS A 901 (-4.7A)4ZS A 901 (-3.2A)4ZS A 901 (-3.6A) | 0.72A | 2y7jA-5ezrA:27.8 | 2y7jA-5ezrA:18.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_B_B49B1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 6 / 10 | ILE A 540VAL A 548ALA A 561ILE A 595LEU A 613ASP A 675 | 4ZS A 901 (-4.2A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A)4ZS A 901 (-4.7A)None | 0.67A | 2y7jB-5ezrA:27.7 | 2y7jB-5ezrA:18.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_B_B49B1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 6 / 10 | ILE A 540VAL A 548ALA A 561ILE A 595LEU A 613LEU A 664 | 4ZS A 901 (-4.2A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A)4ZS A 901 (-4.7A)4ZS A 901 (-3.6A) | 0.51A | 2y7jB-5ezrA:27.7 | 2y7jB-5ezrA:18.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_C_B49C1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 6 / 10 | ILE A 540VAL A 548ALA A 561ILE A 595LEU A 613LEU A 664 | 4ZS A 901 (-4.2A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A)4ZS A 901 (-4.7A)4ZS A 901 (-3.6A) | 0.49A | 2y7jC-5ezrA:27.8 | 2y7jC-5ezrA:18.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_D_B49D1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 6 / 10 | ILE A 540VAL A 548ALA A 561ILE A 595LEU A 613LEU A 664 | 4ZS A 901 (-4.2A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A)4ZS A 901 (-4.7A)4ZS A 901 (-3.6A) | 0.57A | 2y7jD-5ezrA:27.3 | 2y7jD-5ezrA:18.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HEC_A_STIA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 5 / 12 | ALA A 561ILE A 595THR A 611LEU A 613ASP A 675 | 4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A)4ZS A 901 (-3.2A)4ZS A 901 (-4.7A)None | 0.75A | 3hecA-5ezrA:20.3 | 3hecA-5ezrA:17.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HEC_A_STIA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 5 / 12 | ALA A 561LYS A 563ILE A 595THR A 611LEU A 613 | 4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-4.3A)4ZS A 901 (-3.2A)4ZS A 901 (-4.7A) | 0.65A | 3hecA-5ezrA:20.3 | 3hecA-5ezrA:17.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HEG_A_BAXA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 5 / 12 | VAL A 548ALA A 561LYS A 563ILE A 595THR A 611 | 4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-4.3A)4ZS A 901 (-3.2A) | 0.72A | 3hegA-5ezrA:17.7 | 3hegA-5ezrA:17.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LXN_A_MI1A1_1 (NON-RECEPTORTYROSINE-PROTEINKINASE TYK2) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 7 / 12 | GLY A 541VAL A 548ALA A 561LYS A 563ILE A 595VAL A 614LEU A 664 | 4ZS A 901 ( 4.5A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-4.3A)4ZS A 901 (-3.8A)4ZS A 901 (-3.6A) | 0.60A | 3lxnA-5ezrA:21.8 | 3lxnA-5ezrA:14.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OHT_A_1N1A1000_1 (P38A) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 6 / 12 | GLY A 541VAL A 548ALA A 561LYS A 563ILE A 595THR A 611 | 4ZS A 901 ( 4.5A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-4.3A)4ZS A 901 (-3.2A) | 0.49A | 3ohtA-5ezrA:5.0 | 3ohtA-5ezrA:18.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OHT_B_1N1B1000_1 (P38A) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 6 / 12 | GLY A 541VAL A 548ALA A 561LYS A 563ILE A 595THR A 611 | 4ZS A 901 ( 4.5A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-4.3A)4ZS A 901 (-3.2A) | 0.42A | 3ohtB-5ezrA:4.9 | 3ohtB-5ezrA:18.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WAR_A_NIOA401_1 (CASEIN KINASE IISUBUNIT ALPHA) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 4 / 8 | VAL A 548LYS A 563ILE A 595ILE A 674 | 4ZS A 901 (-4.8A)4ZS A 901 (-3.9A)4ZS A 901 (-4.3A)4ZS A 901 (-3.9A) | 0.56A | 3warA-5ezrA:23.5 | 3warA-5ezrA:17.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 6 / 12 | VAL A 548ALA A 561ILE A 595THR A 611LEU A 664ASP A 675 | 4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A)4ZS A 901 (-3.2A)4ZS A 901 (-3.6A)None | 1.03A | 4bkjB-5ezrA:19.5 | 4bkjB-5ezrA:17.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I41_A_MIXA500_1 (SERINE/THREONINE-PROTEIN KINASE PIM-1) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 8 / 12 | VAL A 548ALA A 561ILE A 595ASP A 657ASN A 662LEU A 664ILE A 674ASP A 675 | 4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A)NoneNone4ZS A 901 (-3.6A)4ZS A 901 (-3.9A)None | 0.78A | 4i41A-5ezrA:25.3 | 4i41A-5ezrA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I41_A_MIXA500_1 (SERINE/THREONINE-PROTEIN KINASE PIM-1) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 8 / 12 | VAL A 548ALA A 561ILE A 595ASP A 657LYS A 659ASN A 662LEU A 664ILE A 674 | 4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A)NoneNoneNone4ZS A 901 (-3.6A)4ZS A 901 (-3.9A) | 0.82A | 4i41A-5ezrA:25.3 | 4i41A-5ezrA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IAA_A_RTZA401_1 (SERINE/THREONINE-PROTEIN KINASE PIM-1) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 6 / 11 | VAL A 548ALA A 561LYS A 563LEU A 664ILE A 674ASP A 675 | 4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-3.6A)4ZS A 901 (-3.9A)None | 0.67A | 4iaaA-5ezrA:25.4 | 4iaaA-5ezrA:17.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IFG_A_1E8A601_1 (CALMODULIN-DOMAINPROTEIN KINASE 1) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 8 / 12 | GLY A 541VAL A 548ALA A 561LEU A 597GLY A 617GLU A 618LEU A 664ILE A 674 | 4ZS A 901 ( 4.5A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)None4ZS A 901 ( 3.8A)4ZS A 901 (-3.2A)4ZS A 901 (-3.6A)4ZS A 901 (-3.9A) | 0.68A | 4ifgA-5ezrA:22.7 | 4ifgA-5ezrA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R7I_A_STIA1001_1 (MACROPHAGECOLONY-STIMULATINGFACTOR 1 RECEPTOR) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 6 / 12 | VAL A 548ALA A 561LYS A 563THR A 611LEU A 664ASP A 675 | 4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-3.2A)4ZS A 901 (-3.6A)None | 0.78A | 4r7iA-5ezrA:18.3 | 4r7iA-5ezrA:17.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RZ7_A_1E8A901_1 (CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 10 / 10 | ILE A 540ALA A 561LYS A 563THR A 586ILE A 595PHE A 609THR A 611LEU A 613VAL A 614LEU A 664 | 4ZS A 901 (-4.2A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-3.4A)4ZS A 901 (-4.3A)None4ZS A 901 (-3.2A)4ZS A 901 (-4.7A)4ZS A 901 (-3.8A)4ZS A 901 (-3.6A) | 0.38A | 4rz7A-5ezrA:55.5 | 4rz7A-5ezrA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XV2_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 6 / 12 | VAL A 548ALA A 561LYS A 563THR A 611ASP A 675PHE A 676 | 4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-3.2A)None4ZS A 901 (-4.9A) | 0.88A | 4xv2A-5ezrA:19.5 | 4xv2A-5ezrA:17.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XV2_B_P06B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 5 / 12 | ALA A 561LYS A 563THR A 611ASP A 675PHE A 676 | 4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-3.2A)None4ZS A 901 (-4.9A) | 0.85A | 4xv2B-5ezrA:19.7 | 4xv2B-5ezrA:17.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CSW_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 5 / 12 | VAL A 548ALA A 561LYS A 563THR A 611PHE A 676 | 4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-3.2A)4ZS A 901 (-4.9A) | 0.79A | 5cswA-5ezrA:19.4 | 5cswA-5ezrA:16.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CSW_B_P06B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 5 / 12 | VAL A 548ALA A 561LYS A 563THR A 611PHE A 676 | 4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-3.2A)4ZS A 901 (-4.9A) | 0.78A | 5cswB-5ezrA:19.5 | 5cswB-5ezrA:16.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ESL_A_1YNA701_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 4 / 5 | ALA A 634TYR A 637GLY A 543LEU A 664 | NoneNoneNone4ZS A 901 (-3.6A) | 1.02A | 5eslA-5ezrA:undetectable | 5eslA-5ezrA:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LW1_B_ADNB401_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 8) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 5 / 9 | ILE A 540GLY A 541VAL A 548ALA A 561ILE A 595 | 4ZS A 901 (-4.2A)4ZS A 901 ( 4.5A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A) | 0.27A | 5lw1B-5ezrA:21.9 | 5lw1B-5ezrA:7.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LW1_E_ADNE401_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 8) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 5 / 10 | GLY A 541VAL A 548ALA A 561ILE A 595LEU A 613 | 4ZS A 901 ( 4.5A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-4.3A)4ZS A 901 (-4.7A) | 0.42A | 5lw1E-5ezrA:21.8 | 5lw1E-5ezrA:7.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y80_A_IREA401_0 (CYCLIN-G-ASSOCIATEDKINASE) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 7 / 12 | VAL A 548ALA A 561LYS A 563THR A 611LEU A 613LEU A 664ASP A 675 | 4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-3.2A)4ZS A 901 (-4.7A)4ZS A 901 (-3.6A)None | 0.57A | 5y80A-5ezrA:23.5 | 5y80A-5ezrA:7.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YF9_B_NIOB401_1 (CASEIN KINASE IISUBUNIT ALPHA') |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 4 / 7 | VAL A 548LYS A 563ILE A 674ASP A 675 | 4ZS A 901 (-4.8A)4ZS A 901 (-3.9A)4ZS A 901 (-3.9A)None | 0.82A | 5yf9B-5ezrA:22.1 | 5yf9B-5ezrA:9.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YF9_X_NIOX401_1 (CASEIN KINASE IISUBUNIT ALPHA') |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 5 / 9 | VAL A 548LYS A 563ILE A 595ILE A 674ASP A 675 | 4ZS A 901 (-4.8A)4ZS A 901 (-3.9A)4ZS A 901 (-4.3A)4ZS A 901 (-3.9A)None | 0.82A | 5yf9X-5ezrA:22.4 | 5yf9X-5ezrA:9.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YWM_X_NIOX403_0 (CASEIN KINASE IISUBUNIT ALPHA') |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 4 / 7 | LYS A 563ILE A 595ILE A 674ASP A 675 | 4ZS A 901 (-3.9A)4ZS A 901 (-4.3A)4ZS A 901 (-3.9A)None | 0.60A | 5ywmX-5ezrA:22.3 | 5ywmX-5ezrA:9.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YWM_X_NIOX403_0 (CASEIN KINASE IISUBUNIT ALPHA') |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 4 / 7 | VAL A 548LYS A 563ILE A 595ILE A 674 | 4ZS A 901 (-4.8A)4ZS A 901 (-3.9A)4ZS A 901 (-4.3A)4ZS A 901 (-3.9A) | 0.41A | 5ywmX-5ezrA:22.3 | 5ywmX-5ezrA:9.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZV2_A_LEVA801_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 1) |
5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) | 3 / 3 | LYS A 563LEU A 664ASP A 675 | 4ZS A 901 (-3.9A)4ZS A 901 (-3.6A)None | 0.84A | 5zv2A-5ezrA:18.3 | 5zv2A-5ezrA:7.52 |